Nwam LLC Buys 46 Shares of Stryker Co. (NYSE:SYK)

Nwam LLC raised its position in shares of Stryker Co. (NYSE:SYK) by 2.1% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 2,214 shares of the medical technology company’s stock after acquiring an additional 46 shares during the period. Nwam LLC’s holdings in Stryker were worth $740,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently made changes to their positions in SYK. Aspen Investment Management Inc grew its holdings in Stryker by 0.7% in the 1st quarter. Aspen Investment Management Inc now owns 4,368 shares of the medical technology company’s stock valued at $1,563,000 after buying an additional 31 shares in the last quarter. Harbor Investment Advisory LLC increased its position in Stryker by 0.4% during the first quarter. Harbor Investment Advisory LLC now owns 6,982 shares of the medical technology company’s stock worth $2,499,000 after acquiring an additional 31 shares during the period. Proficio Capital Partners LLC raised its stake in Stryker by 2.4% in the 1st quarter. Proficio Capital Partners LLC now owns 1,418 shares of the medical technology company’s stock worth $507,000 after purchasing an additional 33 shares in the last quarter. Simon Quick Advisors LLC boosted its holdings in Stryker by 3.0% in the 4th quarter. Simon Quick Advisors LLC now owns 1,158 shares of the medical technology company’s stock valued at $347,000 after purchasing an additional 34 shares during the period. Finally, Consolidated Portfolio Review Corp grew its position in shares of Stryker by 3.6% during the 4th quarter. Consolidated Portfolio Review Corp now owns 983 shares of the medical technology company’s stock worth $294,000 after purchasing an additional 34 shares in the last quarter. Institutional investors and hedge funds own 77.09% of the company’s stock.

Stryker Stock Up 2.9 %

Shares of NYSE SYK opened at $340.95 on Friday. The company has a 50 day simple moving average of $338.30 and a 200 day simple moving average of $337.75. The company has a debt-to-equity ratio of 0.56, a current ratio of 1.71 and a quick ratio of 0.99. Stryker Co. has a 1 year low of $249.98 and a 1 year high of $361.41. The firm has a market cap of $129.88 billion, a PE ratio of 38.92, a price-to-earnings-growth ratio of 2.68 and a beta of 0.89.

Stryker (NYSE:SYK) last issued its quarterly earnings results on Tuesday, April 30th. The medical technology company reported $2.50 EPS for the quarter, topping analysts’ consensus estimates of $2.36 by $0.14. The company had revenue of $5.24 billion for the quarter, compared to analyst estimates of $5.10 billion. Stryker had a net margin of 16.03% and a return on equity of 23.05%. Stryker’s revenue was up 9.7% compared to the same quarter last year. During the same quarter in the previous year, the business earned $2.14 earnings per share. On average, research analysts forecast that Stryker Co. will post 11.95 EPS for the current year.

Stryker Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, July 31st. Investors of record on Friday, June 28th will be issued a $0.80 dividend. This represents a $3.20 annualized dividend and a yield of 0.94%. The ex-dividend date is Friday, June 28th. Stryker’s payout ratio is presently 36.53%.

Wall Street Analyst Weigh In

SYK has been the subject of several recent research reports. The Goldman Sachs Group assumed coverage on Stryker in a research note on Thursday, May 30th. They issued a “neutral” rating and a $372.00 price target for the company. BTIG Research raised their price target on Stryker from $369.00 to $372.00 and gave the stock a “buy” rating in a research report on Monday, July 15th. Robert W. Baird boosted their price target on Stryker from $367.00 to $378.00 and gave the company an “outperform” rating in a research note on Wednesday, May 1st. Citigroup raised their target price on shares of Stryker from $362.00 to $406.00 and gave the company a “buy” rating in a report on Wednesday, April 3rd. Finally, Needham & Company LLC raised shares of Stryker from a “hold” rating to a “buy” rating and set a $392.00 price target for the company in a report on Wednesday, May 22nd. Four analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the stock. According to MarketBeat.com, Stryker has an average rating of “Moderate Buy” and an average price target of $372.05.

About Stryker

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.